Evidence map›Paper›PMID 42016177›Full record

ArticlePlastic and reconstructive surgery. Global open2026

Oncoplastic Versus Standard Breast-conserving Surgery: Predictors of Re-excision, Complications, and Safety Outcomes.

Yazeed A Almojel, Raad M Alaql, Abdulaziz M Alghamdi, Mohammed M Alshenaiber, Adham M Alghamdi, Mohammed Aldakhil, Ammar Alsayegh, Deemah S Alharbi, Mohammed D Alqarni, D C Vasilescu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Plastic and reconstructive surgery. Global open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yazeed A AlmojelFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Raad M AlaqlPlastic and Reconstructive Surgery Division, Surgery Department, Ministry of National Guards-Health Affairs, Riyadh, Saudi Arabia.
Abdulaziz M AlghamdiPlastic and Reconstructive Surgery Division, Surgery Department, Ministry of National Guards-Health Affairs, Riyadh, Saudi Arabia.
Mohammed M AlshenaiberFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Adham M AlghamdiFaculty of Medicine, Al-Baha University, Al-Baha, Saudi Arabia.
Mohammed AldakhilFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Ammar AlsayeghCollege of Medicine, Imam Abdulrahman bin Faisal University, Dammam, Saudi Arabia.
Deemah S AlharbiFrom the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.
Mohammed D AlqarniKing Fahad General Hospital, Jeddah, Saudi Arabia.
D C VasilescuPlastic and Reconstructive Surgery Division, Surgery Department, Ministry of National Guards-Health Affairs, Riyadh, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Oncoplastic breast-conserving surgery (OBCS) combines tumor resection with immediate reconstruction to improve cosmetic outcomes and increase breast conservation rates. We compared outcomes of OBCS versus standard breast-conserving surgery (SBCS). Methods: We retrospectively analyzed 237 breast cancer patients (137 OBCS, 100 SBCS) treated from 2020 to 2024. Clinicopathologic factors, complications, re-excision, and recurrence rates were evaluated. Logistic regression was used to identify predictors of re-excision. Results: Re-excision was required in 20.7% of cases, significantly more often after OBCS than SBCS (26.3% versus 13.0%, Conclusions: OBCS had higher positive margin and re-excision rates than SBCS. Improved intraoperative margin assessment and patient selection may reduce re-excision rates.

Identifiers

PMID42016177
PMCPMC13095285

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.